Vivani Medical Inc
VANI1.400USD
+0.070+5.26%
Fechamento 08/04, 16:00（ET）Cotações atrasadas em 15 min
82.94MValor de mercado
PerdaP/L TTM
Mais detalhes de Vivani Medical Inc Empresa
Vivani Medical, Inc. is a biopharmaceutical company developing novel, ultra-long-acting drug implants. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of chronic weight management in obese or overweight individuals. Its pipeline also includes the NPM-139 (semaglutide) implant which is also under development for chronic weight management in obese and overweight individuals. NPM-119 refers to its Type II diabetes development program. OKV-119 is an exenatide implant that is under development for metabolic diseases in cats, including for the treatment of obesity and diabetes. Its segments include Biopharm Division and Neurostimulation Division.
Informações da empresa
Código da empresaVANI
Nome da EmpresaVivani Medical Inc
Data de listagemDec 05, 2014
CEODr. Adam Mendelsohn, Ph.D.
Número de funcionários42
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 05
Endereço1350 S. Loop Road
CidadeALAMEDA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal94502
Telefone14155068462
Sitehttps://vivani.com/
Código da empresaVANI
Data de listagemDec 05, 2014
CEODr. Adam Mendelsohn, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Adam Mendelsohn, Ph.D.
Dr. Adam Mendelsohn, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
3.75M
+1.58%
Mr. Aaron Mendelsohn
Mr. Aaron Mendelsohn
Independent Director
Independent Director
1.09M
--
Mr. Truc Le
Mr. Truc Le
Chief Operating Officer
Chief Operating Officer
46.66K
--
Mr. Donald (Don) Dwyer
Mr. Donald (Don) Dwyer
Corporate Secretary, Chief Business Officer
Corporate Secretary, Chief Business Officer
25.67K
+18.46%
Mr. Anthony Baldor
Mr. Anthony Baldor
Chief Financial Officer
Chief Financial Officer
--
--
Jami Taylor
Jami Taylor
Investor Relations Advisor
Investor Relations Advisor
--
--
Dr. Dean Baker, Ph.D.
Dr. Dean Baker, Ph.D.
Independent Director
Independent Director
--
--
Mr. Gregg G. Williams
Mr. Gregg G. Williams
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Daniel Mark (Dan) Bradbury
Mr. Daniel Mark (Dan) Bradbury
Independent Director
Independent Director
--
--
Ms. Alexandra Larson
Ms. Alexandra Larson
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Adam Mendelsohn, Ph.D.
Dr. Adam Mendelsohn, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
3.75M
+1.58%
Mr. Aaron Mendelsohn
Mr. Aaron Mendelsohn
Independent Director
Independent Director
1.09M
--
Mr. Truc Le
Mr. Truc Le
Chief Operating Officer
Chief Operating Officer
46.66K
--
Mr. Donald (Don) Dwyer
Mr. Donald (Don) Dwyer
Corporate Secretary, Chief Business Officer
Corporate Secretary, Chief Business Officer
25.67K
+18.46%
Mr. Anthony Baldor
Mr. Anthony Baldor
Chief Financial Officer
Chief Financial Officer
--
--
Jami Taylor
Jami Taylor
Investor Relations Advisor
Investor Relations Advisor
--
--
Detalhamento da receita
FY2019
FY2018
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
2.20M
0.00%
Italy
642.04K
0.00%
China
337.90K
0.00%
France
0.00
0.00%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sex, 16 de mai
Atualizado em: sex, 16 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Williams (Gregg)
30.87%
Bolck (Joachim Eberhard)
9.45%
Mendelsohn (Adam)
6.34%
Mendelsohn (Aaron)
1.83%
Tanager Wealth Management LLP
1.72%
Other
49.79%
Investidores
Investidores
Proporção
Williams (Gregg)
30.87%
Bolck (Joachim Eberhard)
9.45%
Mendelsohn (Adam)
6.34%
Mendelsohn (Aaron)
1.83%
Tanager Wealth Management LLP
1.72%
Other
49.79%
Tipos de investidores
Investidores
Proporção
Individual Investor
49.03%
Investment Advisor
4.84%
Investment Advisor/Hedge Fund
2.56%
Hedge Fund
0.28%
Other
43.29%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
69
33.60M
56.72%
-556.17K
2025Q1
72
33.70M
56.88%
-726.81K
2024Q4
67
33.96M
57.33%
+2.68M
2024Q3
70
30.79M
54.55%
-493.25K
2024Q2
72
30.73M
54.46%
-999.37K
2024Q1
71
31.19M
60.37%
+7.51M
2023Q4
76
28.47M
55.90%
+4.85M
2023Q3
88
28.13M
55.24%
+3.68M
2023Q2
94
27.99M
55.13%
+4.81M
2023Q1
98
20.48M
40.40%
+6.26M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Williams (Gregg)
18.29M
30.87%
+105.15K
+0.58%
Apr 22, 2025
Bolck (Joachim Eberhard)
5.60M
9.45%
--
--
Mar 31, 2025
Mendelsohn (Adam)
3.75M
6.34%
+58.33K
+1.58%
Mar 31, 2025
Mendelsohn (Aaron)
1.09M
1.83%
--
--
Mar 31, 2025
Tanager Wealth Management LLP
1.22M
2.07%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
967.40K
1.63%
--
--
Mar 31, 2025
Sabby Management, LLC
851.61K
1.44%
-459.83K
-35.06%
Mar 31, 2025
Geode Capital Management, L.L.C.
360.53K
0.61%
+13.37K
+3.85%
Mar 31, 2025
Commonwealth Financial Network
330.53K
0.56%
--
--
Mar 31, 2025
Baker (Wilford Dean)
197.48K
0.33%
--
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Aug 18, 2022
Merger
3<1
Aug 18, 2022
Merger
3<1
Aug 18, 2022
Merger
3<1
Aug 18, 2022
Merger
3<1
Data
Tipo
Proporção
Aug 18, 2022
Merger
3<1
Aug 18, 2022
Merger
3<1
Aug 18, 2022
Merger
3<1
Aug 18, 2022
Merger
3<1
